Pomegranate for Chemoprevention and Chemotherapy of Prostate Cancer
石榴用于前列腺癌的化学预防和化疗
基本信息
- 批准号:7337139
- 负责人:
- 金额:$ 27.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-01-01 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAge-YearsAmericanAmerican Cancer SocietyAndrogensAngiogenic FactorAnimal ModelAnthocyaninsAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsApoptosisApoptoticAttentionAubergineBerryBiologicalBiological ProcessCWR22Rv1Cancer EtiologyCancer PatientCarrots - dietaryCaspaseCell Culture SystemCell CycleCell DeathCell ProliferationCell SurvivalCellsCessation of lifeChemopreventionChemopreventive AgentCultured CellsCyclin D1Cyclin-Dependent Kinase InhibitorCyclin-Dependent KinasesCyclinsDNA BindingDU145DataDevelopmentDiagnosisDietary InterventionDiseaseDisease ProgressionDoseDown-RegulationDrug resistanceEllagi-TanninsEvaluationEventFamilyFigs - dietaryFruitGelatinase AGelatinase BGenesGeneticGenetic TranscriptionGrapesGreen teaGrowth and Development functionHumanHydrolyzable TanninsI Kappa B-AlphaImplantIn VitroIncidenceInduction of ApoptosisInflammationInflammatoryInfusion proceduresInsulin-Like Growth Factor IInterleukin-2Intervention StudiesInvasiveInvestigationJuiceLNCaPLightMALDI-TOF Mass SpectrometryMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMatrix MetalloproteinasesMediatingMedicalMetastasis InductionMetastatic Prostate CancerModelingMolecularMolecular TargetMusNF-kappa BNeoplasm MetastasisNuclear TranslocationNude MiceOnionsOperative Surgical ProceduresOralOutcome StudyPC3 cell linePCNA genePathway interactionsPhosphorylationPhosphotransferasesPigmentsPlantsPomegranatePopulationPreventionPreventivePrincipal InvestigatorProcessProductionProliferation MarkerPromoter RegionsPropertyProstateProstatic DiseasesProtein FamilyProteinsPublishingPunica granatumReactive Oxygen SpeciesReportingResearch PersonnelRetroviridaeRoleSignal PathwaySignal TransductionSiteSkinSkin CarcinogenesisSomatomedinsSourceSpecimenStagingStimulusTestingTherapeuticTherapeutic EffectTomatoesTransgenic OrganismsTreesTumor Necrosis Factor ReceptorUnited StatesVascular Endothelial Growth FactorsWorkXenograft procedureangiogenesisautocrinec-myc Genescancer cellcancer preventioncancer therapycarcinogenesiscell growthcell typechemotherapycyclin G1cyclin-dependent kinase inhibitor 1Bdelphinidindesigneggfruits and vegetablesgenetic manipulationhuman diseasein vivoinhibitor/antagonistinterestkeratinocytemalemembermenmouse modelmutantneoplastic cellnoveloncoprotein p21paracrinepre-clinicalpreventpromoterprostate cancer preventionprotein expressionreceptorred wineresearch studyresponsesurvivintranscription factortumortumor growthtumorigenesisultraviolet
项目摘要
Identification of novel targets and the development of commonly used and non-toxic dietary agents for prevention and
treatment of prostate cancer (PCa) has become a National Medical Priority. Recent studies have highlighted the role of
the transcription factor NFicB in cancer cell survival. Along these lines many studies have shown that NFxB is
constitutively activated in human PCa cells and specimens. Thus, NFxB has become an important target for developing
novel PCa preventive and therapeutic approaches. Pomegranate derived from the fruit of the tree Punica granatum is
known to possess antioxidant and anti-inflammatory properties. We recently showed that pomegranate fruit extract
(PFE) inhibited tumor development in mouse skin two stage carcinogenesis model through inhibition of the NFicB
signaling pathway. Our unpublished preliminary data showed that PFE is an effective anti-proliferative and pro-
apoptotic agent against human PCa PCS cells. On analysis by MALDI-TOF mass spectrometry, PFE was found to
contain six anthocyanins and several ellagitannins and hydrolyzable tannins. Our preliminary data showed that among
six anthocyanins present in PFE, delphinidin the most abundant was the most effective anti-proliferative agent.
Importantly, delphinidin is known to be present in many other pigmented fruits and vegetables like berries, eggplant,
dark grapes, tomato, carrots and red onions. The primary objective of this proposal is to capitalize on our novel
preliminary findings with delphinidin and PFE in PCa cells and investigate its PCa chemopreventive and/or
chemotherapeutic potential under in vitro and in vivo settings. This choice is made because we believe that cell culture
studies must be conducted with pure agents rather than a mixture of agents and intervention studies must be
conducted with the substances that humans could be persuaded to consume. Using PCa cell lines we will first
investigate the cell death cascade activated by delphinidin and understand how it inhibits cell survival signaling
mediated by NFicB. In particular using genetic manipulation and pharmacological approaches we will investigate the
role of NFicB gene products involved in i) anti-apoptosis (IAP1, xlAP, Bfl-1/A1, Bcl-2, cFLIP, and survivin), ii)
proliferation (cyclin D1 and c-Myc), iii) inflammation (Cox-2, PPARy and iNOS) and iv) metastasis (MMP-9, MMP-2 and
VEGF). We will then define PCa chemopreventive/therapeutic potential of PFE under in vivo situation using established
transgenic and xenograft mouse models. To have relevance to human population, we reasoned that efficacy studies
must be conducted in an animal model where disease progression occurs akin to humans. Employing i) TRAMP, a
model that mimics progressive forms of human prostatic disease and ii) athymic nude mouse implanted with human
PCa cells we will establish the cancer chemopreventive/therapeutic potential of PFE. PUBLIC RELEVANCE: This
proposal will establish the molecular targets for prostate cancer prevention and treatment and in addition will draw
attention to the use of pomegranate and other pigmented fruits and vegetables for prevention against prostate cancer.
确定新靶点并开发常用且无毒的膳食制剂以预防和治疗
前列腺癌(PCa)的治疗已成为国家医疗重点。最近的研究强调了
转录因子 NFicB 在癌细胞存活中的作用。沿着这些思路,许多研究表明 NFxB
在人 PCa 细胞和样本中组成型激活。因此,NFxB已成为发展的重要目标。
新的 PCa 预防和治疗方法。石榴是从石榴树的果实中提取出来的
已知具有抗氧化和抗炎特性。我们最近证明石榴果提取物
(PFE) 通过抑制 NFicB 抑制小鼠皮肤两阶段癌变模型中的肿瘤发展
信号通路。我们未发表的初步数据表明,PFE 是一种有效的抗增殖和促增殖药物。
针对人 PCa PCS 细胞的凋亡剂。通过 MALDI-TOF 质谱分析,发现 PFE
含有六种花青素和几种鞣花单宁和可水解单宁。我们的初步数据显示,其中
PFE中存在的六种花青素中,飞燕草素含量最丰富,也是最有效的抗增殖剂。
重要的是,飞燕草素已知存在于许多其他有色素的水果和蔬菜中,如浆果、茄子、
黑葡萄、番茄、胡萝卜和红洋葱。该提案的主要目标是利用我们的小说
飞燕草素和 PFE 在 PCa 细胞中的初步研究结果,并研究其 PCa 化学预防和/或
体外和体内环境下的化疗潜力。做出这个选择是因为我们相信细胞培养
研究必须使用纯药物而不是药物混合物进行,并且干预研究必须
使用可以说服人类消费的物质进行。使用 PCa 细胞系,我们首先
研究飞燕草素激活的细胞死亡级联并了解它如何抑制细胞生存信号传导
由 NFicB 介导。特别是使用基因操作和药理学方法,我们将研究
NFicB 基因产物参与 i) 抗凋亡(IAP1、xlAP、Bfl-1/A1、Bcl-2、cFLIP 和 survivin),ii) 的作用
增殖(细胞周期蛋白 D1 和 c-Myc),iii) 炎症(Cox-2、PPARy 和 iNOS)和 iv) 转移(MMP-9、MMP-2 和
血管内皮生长因子)。然后,我们将使用已建立的方法来定义 PFE 在体内情况下的 PCa 化学预防/治疗潜力
转基因和异种移植小鼠模型。为了与人群相关,我们推断功效研究
必须在疾病进展类似于人类的动物模型中进行。雇用 i) TRAMP,
模拟人类前列腺疾病进展形式的模型和 ii) 植入人类前列腺的无胸腺裸鼠
我们将通过 PCa 细胞确定 PFE 的癌症化学预防/治疗潜力。公众相关性:这
该提案将建立前列腺癌预防和治疗的分子目标,此外还将绘制
注意利用石榴等色素水果和蔬菜来预防前列腺癌。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hasan Mukhtar其他文献
Hasan Mukhtar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hasan Mukhtar', 18)}}的其他基金
Defining the role of miR-30 in human skin
定义 miR-30 在人类皮肤中的作用
- 批准号:
8813976 - 财政年份:2014
- 资助金额:
$ 27.93万 - 项目类别:
Defining the role of miR-30 in human skin
定义 miR-30 在人类皮肤中的作用
- 批准号:
8923147 - 财政年份:2014
- 资助金额:
$ 27.93万 - 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
- 批准号:
8278499 - 财政年份:2011
- 资助金额:
$ 27.93万 - 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
- 批准号:
9064262 - 财政年份:2011
- 资助金额:
$ 27.93万 - 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
- 批准号:
8644570 - 财政年份:2011
- 资助金额:
$ 27.93万 - 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
- 批准号:
8278499 - 财政年份:2011
- 资助金额:
$ 27.93万 - 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
- 批准号:
8681386 - 财政年份:2011
- 资助金额:
$ 27.93万 - 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
- 批准号:
8473681 - 财政年份:2011
- 资助金额:
$ 27.93万 - 项目类别:
Developing Fisetin for the Managment of Prostate Cancer
开发非瑟酮治疗前列腺癌
- 批准号:
8160855 - 财政年份:2011
- 资助金额:
$ 27.93万 - 项目类别:
相似海外基金
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)
停止使用羟氯喹治疗老年狼疮病 (SHIELD)
- 批准号:
10594743 - 财政年份:2023
- 资助金额:
$ 27.93万 - 项目类别:
Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA)
芝加哥不同高危女性人群乳腺癌替代预防研究 (CAPSBRACA)
- 批准号:
10737279 - 财政年份:2023
- 资助金额:
$ 27.93万 - 项目类别:
Health and Financial Costs of Unequal Care: Colorectal Cancer as a Case Study
不平等护理的健康和财务成本:结直肠癌案例研究
- 批准号:
10656807 - 财政年份:2023
- 资助金额:
$ 27.93万 - 项目类别:
Virus and olfactory system interactions accelerate Alzheimer's disease pathology
病毒和嗅觉系统相互作用加速阿尔茨海默病病理学
- 批准号:
10669880 - 财政年份:2023
- 资助金额:
$ 27.93万 - 项目类别:
Indicators of Accelerated Aging in Asian American Childhood Survivors
亚裔美国童年幸存者加速衰老的指标
- 批准号:
10910604 - 财政年份:2023
- 资助金额:
$ 27.93万 - 项目类别: